Schroder Investment Management Group Cue Biopharma, Inc. Transaction History

Schroder Investment Management Group

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$11.12 - $16.4 $585,568 - $863,607	-52,659 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$15.05 - $23.54 $371,479 - $581,037	-24,683 Reduced 31.91%	52,659 $821,000
Q2 2020 Aug 13, 2020	SELL	$12.7 - $30.73 $200,736 - $485,718	-15,806 Reduced 16.97%	77,342 $1.9 Million
Q1 2020 May 15, 2020	BUY	$9.85 - $22.27 $4,137 - $9,353	420 Added 0.45%	93,148 $1.33 Million
Q4 2019 Feb 11, 2020	BUY	$7.06 - $17.47 $654,659 - $1.62 Million	92,728 New	92,728 $1.47 Million

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

Stay updated on Schroder Investment Management Group with notifications on news.